EUVIMEDOntdek EUVIMED
ÜbersichtsarbeitOpen access

Emerging Roles of PTTG1/Securin in Breast Cancer

Lingyuan Min, Shaojie Feng, Xiuxiu Liu, Yan Zhang, Mengmeng Zhao, Huan Shi, Xianqiang Liu, Tianning Wang

Journal of Cancer · 2025-10-27 · 16 (15) · 4346-4356

DOI: 10.7150/jca.121650 ↗

At a glance

Übersichtsarbeit in Journal of Cancer, published on 2025-10-27. Written by Lingyuan Min and 7 co-authors. Institution: Breast Disease Diagnosis and Treatment Center/Department of Thyroid Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan,…. Cited 5 times so far (Crossref). The full text is freely available in PubMed Central.

SamenvattingSubjectsBibliografische gegevensCiteRelated studies

Abstract (original language)

Securin is a key regulator of chromosome segregation during mitosis. Dysregulation of securin triggers chromosomal instability (CIN) and aneuploidy, which are hallmarks of many solid tumors, including breast cancer (BC). Recent studies have revealed securin's multifaceted roles in the progression of BC. Overexpression of securin not only enhances the malignant behaviors of BC cells but also correlates with poor clinical outcomes in patients, suggesting its potential as both a therapeutic target and prognostic biomarker. Although interest in securin is growing, comprehensive reviews on its role in BC are sparse. In this review, we summarize the biological function of securin. We then focus on the expression patterns of securin in BC and related experimental models, and their association with CIN. Subsequently, we discuss the significance of securin as a prognostic marker for BC. Lastly, we explore how securin influences the malignant behaviors of BC cells. This review emphasizes the critical connection between CIN and BC pathobiology mediated by securin and offers insights for future research into securin-related mechanisms and therapeutic strategies.

Subjects

Author keywords

PTTG1breast cancerchromosomal instabilitysecurintumor progression

Authors and institutions

  • Breast Disease Diagnosis and Treatment Center/Department of Thyroid Surgery, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, China.
  • Research Center of Translational Medicine, Central Hospital Affiliated to Shandong First Medical University, Jinan, 250013, China.
  • Department of Internal Medicine-Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China.

Cite

APA

Min, L., Feng, S., Liu, X., Zhang, Y., Zhao, M., Shi, H., Liu, X., & Wang, T. (2025). Emerging Roles of PTTG1/Securin in Breast Cancer. Journal of Cancer, 16(15), 4346-4356. https://doi.org/10.7150/jca.121650

Vancouver

Min L, Feng S, Liu X, Zhang Y, Zhao M, Shi H, et al. Emerging Roles of PTTG1/Securin in Breast Cancer. Journal of Cancer. 2025;16(15):4346-4356. doi:10.7150/jca.121650

BibTeX
@article{Min2025,
  author = {Min, Lingyuan and Feng, Shaojie and Liu, Xiuxiu and Zhang, Yan and Zhao, Mengmeng and Shi, Huan and Liu, Xianqiang and Wang, Tianning},
  title = {Emerging Roles of PTTG1/Securin in Breast Cancer},
  journal = {Journal of Cancer},
  year = {2025},
  volume = {16},
  number = {15},
  pages = {4346--4356},
  doi = {10.7150/jca.121650}
}
Start for free →